AdaptHealth Corp. AHCO
5.64
0.07
1.26%
as of 25 Sep
- Market cap
- $756.7M
- P/E
- 0.0×
Follow AHCO
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 15.61 | 0.00 | 40.29 | 21.84 | 0.00 | 0.00 | 4.81 | — |
P/S ratio |
0.41 | 0.39 | 0.30 | 0.87 | 1.25 | 1.84 | 0.47 | 0.00 | — |
P/FCF ratio |
6.14 | 5.28 | 6.80 | 0.00 | 42.69 | 12.65 | 6.34 | 1.71 | — |
P/Operating CF |
7.35 | 8.47 | 6.27 | 26.77 | 30.61 | 39.16 | 14.36 | 1.68 | — |
P/B ratio |
0.88 | 0.81 | 0.66 | 1.20 | 1.49 | 7.02 | 0.00 | 1.14 | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Sales |
0.93 | 0.97 | 0.96 | 1.60 | 2.09 | 2.48 | 1.08 | 0.00 | — |
EV/EBITDA |
4.96 | 4.89 | 4.94 | 8.67 | 10.43 | 16.50 | 6.15 | 0.00 | — |
EV/Operating CF |
5.00 | 5.85 | 6.38 | 12.68 | 18.66 | 13.58 | 9.50 | 3.31 | — |
EV/FCF |
13.71 | 13.15 | 21.42 | (270.04) | 71.07 | 17.04 | 14.68 | 3.31 | — |
Quick Ratio |
0.67 | 0.91 | 0.87 | 0.89 | 1.02 | 0.64 | 1.01 | 0.58 | 0.42 |
Current Ratio |
1.02 | 1.33 | 1.21 | 1.28 | 1.34 | 0.86 | 1.18 | 0.67 | 0.42 |
Net Debt/EBITDA |
2.74 | 2.93 | 3.37 | 3.92 | 4.17 | 4.25 | 3.50 | 1.35 | 0.00 |
Debt/Assets |
40.98% | 44.70% | 48.15% | 42.00% | 41.97% | 43.27% | 73.74% | 36.42% | 0.00% |
Debt/Equity |
1.16 | 1.27 | 1.48 | 1.02 | 1.07 | 2.79 | (10.56) | 1.31 | 0.00 |
Asset Turnover |
0.74 | 0.73 | 0.66 | 0.57 | 0.70 | 0.91 | 1.16 | 1.87 | 0.00 |
Operating CF/Net income |
(8.50) | 5.99 | (0.71) | 5.89 | 1.94 | (1.21) | (2.83) | 2.94 | 0.00 |
Capex/Depreciation |
(0.74) | (0.78) | (0.28) | (1.10) | (0.76) | (0.44) | (0.33) | (0.20) | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (4.56%) | 5.94% | (37.46%) | 3.00% | 12.08% | (133.20%) | (66.05%) | 45.26% | 0.00% | |
| (1.61%) | 2.01% | (13.96%) | 1.21% | 4.01% | (13.70%) | (4.66%) | 12.60% | 0.00% | |
ROIC |
1.78% | 4.74% | (10.50%) | 2.77% | 3.42% | 4.62% | 6.38% | 9.17% | 0.00% |
Return on Tangible Assets |
(13.45%) | 13.63% | (111.82%) | 10.30% | 24.93% | (312.84%) | (23.47%) | 139.16% | 0.00% |
Average Days of Receivables |
41.72 | 45.67 | 44.36 | 44.13 | 53.29 | 58.32 | 54.18 | 56.04 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
11.78% | 11.02% | 10.46% | 10.93% | 6.79% | 8.34% | 10.67% | 5.23% | 0.00% |
Intangible Assets out of Total Assets |
0.61 | 0.62 | 0.63 | 0.71 | 0.71 | 0.61 | 0.49 | 0.55 | 0.00 |
Share Based Compensation of Revenue |
0.67% | 0.46% | 0.70% | 0.75% | 1.03% | 1.74% | 2.09% | 0.26% | — |
Graham Net Nets |
(1.53) | (1.69) | (2.46) | (0.95) | (0.81) | (0.59) | (1.63) | (1.50) | — |
Graham Number |
0.00 | 12.73 | 0.00 | 13.18 | 20.31 | 0.00 | 6.17 | 19.94 | — |
Earnings Yield |
(5.42%) | 6.41% | (69.83%) | 2.48% | 4.58% | (6.94%) | (9.13%) | 20.81% | — |
Free Cash Flow Yield |
16.30% | 18.93% | 14.70% | (0.68%) | 2.34% | 7.91% | 15.78% | 58.50% | — |
Revenue per Share |
24.01 | 24.38 | 23.85 | 22.14 | 19.52 | 20.40 | 23.48 | 29.02 | 0.00 |
Operating CF per Share |
4.45 | 4.05 | 3.58 | 2.79 | 2.18 | 3.73 | 2.68 | 5.75 | 0.00 |
Capex per Share |
(2.83) | (2.25) | (2.52) | (2.92) | (1.61) | (0.76) | (0.95) | (0.84) | 0.00 |
Free Cash Flow per Share |
1.62 | 1.80 | 1.07 | (0.13) | 0.57 | 2.97 | 1.73 | 4.91 | 0.00 |
Cash per Share |
0.79 | 0.82 | 0.57 | 0.34 | 1.18 | 1.90 | 3.41 | 2.12 | 0.00 |
Shareholders Equity per Share |
11.29 | 11.80 | 10.93 | 16.08 | 16.36 | 5.35 | (1.69) | 8.64 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
11.29 | 11.80 | 10.93 | 16.08 | 16.36 | 5.35 | (1.69) | 8.64 | 0.00 |
Free Cash Flow |
219.38 | 241.10 | 143.20 | (17.56) | 72.37 | 155.88 | 39.09 | 58.48 | — |
Working Capital |
16.51 | 188.80 | 112.02 | 129.09 | 170.25 | (58.80) | 27.36 | (44.89) | (0.17) |
Capital Expenditures |
(382.39) | (300.74) | (337.46) | (391.42) | (203.31) | (39.75) | (21.33) | (9.95) | — |
Net Current Asset Value |
(2,061.35) | (2,153.04) | (2,392.96) | (2,476.52) | (2,513.74) | (1,169.38) | (403.27) | (175.40) | (0.17) |
EV/EBIT |
33.11 | 12.02 | 0.00 | 24.90 | 22.80 | 37.23 | 19.53 | 7.27 | — |
Capex to Sales |
0.12 | 0.09 | 0.11 | 0.13 | 0.08 | 0.04 | 0.04 | 0.03 | — |
Net Profit Margin |
(2.18%) | 2.77% | (21.21%) | 2.14% | 5.75% | (15.10%) | (4.03%) | 6.74% | 0.00% |
Price to Operating Income |
14.81 | 4.83 | 0.00 | 13.63 | 13.69 | 27.63 | 8.43 | 0.00 | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
1.01 | 0.81 | 2.46 | 0.73 | 0.67 | 0.81 | 1.01 | 0.80 | — |
Cash ROIC |
2.70% | 1.82% | (0.39%) | (2.58%) | (2.78%) | 7.31% | (0.71%) | 2.60% | 0.00% |
Accounts Receivable Turnover |
8.33 | 8.18 | 8.56 | 8.26 | 9.29 | 8.58 | 8.05 | 5.23 | — |
Accounts Payable Turnover |
5.32 | 6.22 | 7.06 | 6.87 | 6.56 | 5.04 | 4.68 | 6.85 | 0.00 |
Inventory Turnover |
18.11 | 20.36 | 21.34 | 19.06 | 22.09 | 24.95 | 42.15 | 27.94 | — |
Average Days of Payables |
76.68 | 61.97 | 55.54 | 51.53 | 65.11 | 103.26 | 85.08 | 106.44 | 0.00 |
Days of Inventory on Hand |
20.95 | 19.78 | 16.10 | 19.51 | 22.37 | 23.88 | 10.96 | 9.55 | — |
Average Receivables |
389.46 | 398.46 | 374.03 | 359.52 | 265.48 | 124.84 | 65.82 | 66.00 | — |
Average Payables |
495.84 | 414.99 | 364.75 | 347.94 | 306.30 | 178.47 | 94.14 | 42.81 | 35.53 |
Average Inventory |
145.54 | 126.74 | 120.70 | 125.42 | 90.94 | 36.01 | 10.46 | 10.50 | — |
Average Assets |
4,401.76 | 4,497.80 | 4,864.12 | 5,235.04 | 3,531.98 | 1,180.01 | 457.75 | 184.63 | 186.50 |
Average Common Equity |
1,552.22 | 1,522.39 | 1,812.21 | 2,112.22 | 1,173.77 | 121.35 | 32.31 | 51.40 | 50.00 |
Columns are period end dates